You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Experimental Vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Pneumonia Trial in Shang Qiu (Experimental Vaccine 1, Experimental Vaccine 2, Experimental Vaccine 3)

Active, not recruiting
  • COVID-19 Pneumonia
  • Experimental Vaccine 1
  • +3 more
  • Shang Qiu, He Nan, China
    Ning ling Center for Disease Control and Prevention
Jul 20, 2022

COVID-19 Trial in Tongren (Experimental vaccine 1, Experimental vaccine 2, Experimental vaccine 3)

Suspended
  • COVID-19
  • Experimental vaccine 1
  • +2 more
  • Tongren, Guizhou, China
    Yanhe Tujia Autonomous County Center for Disease Control and Pre
Aug 9, 2022

Hand, Foot and Mouth Disease Trial in Lincang (Experimental Vaccine, Control Vaccine)

Not yet recruiting
  • Hand, Foot and Mouth Disease
  • Experimental Vaccine
  • Control Vaccine
  • Lincang, Yunnan, China
    Yun County Center for Disease Control and Prevention
Jun 7, 2022

Vaccine Response Impaired Trial in Adelaide (BCG vaccine, Yellow Fever vaccine, Vancomycin Oral Capsule)

Recruiting
  • Vaccine Response Impaired
  • BCG vaccine
  • +3 more
  • Adelaide, South Australia, Australia
    South Australian Health and Medical Research Institute
Nov 17, 2023

Poliomyelitis Trial in Kaifeng, Xuchang (Experimental vaccine, IPV control vaccine, single-person sIPV control vaccine)

Active, not recruiting
  • Poliomyelitis
  • Experimental vaccine
  • +2 more
  • Kaifeng, Henan, China
  • +1 more
May 24, 2022

Infectious Disease, Yellow Fever, Japanese Encephalitis Trial (Stamaril, Imojev, Ixiaro)

Not yet recruiting
  • Infectious Disease
  • +3 more
  • Stamaril
  • +2 more
  • (no location specified)
Oct 3, 2022

Pneumococcal Infections Trial in Yuanping, Yuncheng (Experimental 23-valent Pneumococcal)

Not yet recruiting
  • Pneumococcal Infections
  • Experimental 23-valent Pneumococcal
  • Yuanping, Shanxi, China
  • +1 more
Feb 7, 2023

Malaria,Falciparum Trial in Sigle (Rabies vaccine, RH5.1 10µg adjuvated with 50µg Matrix-M, RH5.2 5µg adjuvated with 50µg

Recruiting
  • Malaria,Falciparum
  • Rabies vaccine
  • +2 more
  • Sigle, Boulkiemdé Province, Burkina Faso
    Institut de Recherche en Sciences de la Santé
Apr 3, 2023

Gonorrhea Male Trial in Chapel Hill (Cefixime, Ceftriaxone, Ciprofloxacin)

Recruiting
  • Gonorrhea Male
  • Chapel Hill, North Carolina
    Clinical and Translational Research Center (CTRC) at University
May 19, 2022

Influenza Prevention Trial in Lenexa, Metairie, Cincinnati (INFLUENZA G1 mHA, Placebo, Al(OH)3)

Recruiting
  • Influenza Prevention
  • INFLUENZA G1 mHA
  • +2 more
  • Lenexa, Kansas
  • +2 more
Jun 5, 2023

Malaria, Malaria,Falciparum, Parasitic Disease Trial in Oxford (RH5.1 and/or RH5.2-VLP with Matrix-M)

Not yet recruiting
  • Malaria
  • +4 more
  • RH5.1 and/or RH5.2-VLP with Matrix-M
  • Oxford, Oxfordshire, United Kingdom
    Centre for Clinical Vaccinology & Tropical Medicine (CCVTM)
Jul 27, 2023

Malaria, Plasmodium Falciparum Trial (Matrix-M with RH5.2 VLP and/or R21)

Not yet recruiting
  • Malaria, Plasmodium Falciparum
  • Matrix-M with RH5.2 VLP and/or R21
  • (no location specified)
Oct 21, 2022

Pneumococcal Infections Trial in Weinan (Experimental 23-valent PPV, Control 23-valent PPV)

Not yet recruiting
  • Pneumococcal Infections
  • Experimental 23-valent PPV
  • Control 23-valent PPV
  • Weinan, Shanxi, China
    Linwei District Center for Disease Control and Prevention
Jul 26, 2022

COVID-19 Trial in Yangchun, Zhenjiang (Experimental Group)

Completed
  • COVID-19
  • Experimental Group
  • Yangchun, Guangdong, China
  • +1 more
Aug 10, 2022

Shigella Trial in Baltimore (SF2a-TT15 Shigella Vaccine, Placebo, S. flexneri 2a strain 2457T Challenge Agent)

Recruiting
  • Shigella
  • SF2a-TT15 Shigella Vaccine
  • +2 more
  • Baltimore, Maryland
    University of Maryland, Baltimore, Center for Vaccine Developmen
May 5, 2022

HIV-1-infection Trial in Kenya, Uganda, Zambia (Vaccine, Placebo)

Active, not recruiting
  • HIV-1-infection
  • Vaccine
  • Placebo
  • Kilifi, Kenya
  • +3 more
Jun 21, 2022

First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney

Active, not recruiting
  • Kidney Diseases
  • +5 more
  • Booster dose of mRNA vaccine
  • Praha, Czechia
    Institute for Clinical and Experimental Medicine
Aug 2, 2022

IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney

Active, not recruiting
  • Kidney Transplantation
  • anti-spike SARS-CoV-2 IgG
  • Prague, Czechia
    Institute for Clinical and Experimental Medicine
Dec 16, 2021

HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus

Completed
  • HPV Infections
  • +14 more
  • Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
  • Active Comparator: GARDASIL ®9
  • Guangxi, China
    Guangxi Zhuang Autonomous Region Center for Disease Control and
May 9, 2022

COVID-19 Vaccine Knowledge, COVID-19 Vaccine Beliefs Trial in Stanford (COVID-19 Vaccine IVR Training, Control Condition)

Completed
  • COVID-19 Vaccine Knowledge
  • COVID-19 Vaccine Beliefs
  • COVID-19 Vaccine IVR Training
  • Control Condition
  • Stanford, California
    Stanford University
Feb 17, 2022

COVID-19 Trial in Yangchun, Zhanjiang (Experimental Group, Control Group)

Not yet recruiting
  • COVID-19
  • Experimental Group1
  • +2 more
  • Huai'an, Jiangsu, China
  • +2 more
Aug 4, 2021

Malaria Trial in Baltimore (VRC-MALMAB0100-00-AB, CHMI)

Completed
  • Malaria
  • Baltimore, Maryland
    University of Maryland Baltimore, Center for Vaccine Development
Nov 9, 2022

Iron Deficiency Anemia, Vaccine Preventable Disease, Vaccine Response Impaired Trial in Msambweni (Ferinject)

Completed
  • Iron Deficiency Anemia
  • +3 more
  • Ferinject
  • Msambweni, Kwale, Kenya
    Msambweni County Referral Hospital
Sep 10, 2021

COVID-19 Trial in Dali (Experimental Group)

Recruiting
  • COVID-19
  • Experimental Group
  • Dali, Yunnan, China
    Yongping Center for Diseases Control and Prevention
Oct 28, 2021

COVID-19 Trial in Dali (Experimental Group)

Recruiting
  • COVID-19
  • Experimental Group
  • Dali, Yunnan, China
    Yongping Center for Diseases Control and Prevention
Oct 28, 2021